Marek Lommatzsch

11PUBLICATIONS
22CO-AUTHORS
Disease surveillanceGene and molecular therapyMolecular targetsAllergyEnvironmental epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Oct 29, 2025
Early and Sustained Asthma Control and Remission in Real-World Patients With Severe Eosinophilic Asthma Treated With Benralizumab: XALOC-2.

Erika Penz, Thomas Rothe, Lieven Dupont

|May 30, 2025
Advancing Remission in Severe Asthma With Benralizumab: Latest Findings, Current Perspectives and Future Direction.

Renaud Louis, Marek Lommatzsch, David J Jackson

|Dec 26, 2023
Tezepelumab in patients with allergic and eosinophilic asthma.

Marco Caminati, Roland Buhl, Jonathan Corren

|Mar 08, 2023
Dupilumab treatment increases transitional B cells in severe asthma.

Marek Lommatzsch, Marieke Dost, Neeraja Jaishankar

|May 19, 2022
Safety of combining biologics in severe asthma: Asthma-related and unrelated combinations.

Marek Lommatzsch, Hendrik Suhling, Stephanie Korn

Pageof 2